Corbus Pharmaceuticals's total assets for Q3 2025 were $109.51M, a decrease of -12.45% from the previous quarter. CRBP total liabilities were $17.37M for the fiscal quarter, a 23.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.